VPS9D1 and colorectal cancer: (D), (E) FCM determination demonstrated that colorectal cancer patients with positive VPS9D1-AS1 expression had lower levels of IFNAR1 in CD4+ and higher levels of PD1 in CD8+ T cells in peripheral blood than these patients with negative VPS9D1-AS1 expression.